12:27 PM EDT, 10/31/2025 (MT Newswires) -- Intensity Therapeutics ( INTS ) said Friday it has struck a deal to sell 5 million shares to a new "fundamental" investor at $0.80 apiece in a direct offering to raise about $4 million.

The stock closed at $1.32 on Thursday.

Net proceeds will be used for clinical trials, working capital and general corporate purposes, the late-stage clinical biotechnology company said. It expects to close the offering Nov. 3.

Shares were down about 37% in recent trading.

Price: 0.83, Change: -0.49, Percent Change: -37.28